News Releases

Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.

Month Year

Jun 4, 2009

Astellas Adds CNS Therapy Area Leader to Global R&D Team
Jun 1, 2009

Astellas Hires New Vice President of Compliance
May 30, 2009

Data from the Phase III ATLAS Study Show Tarceva in Combination with Avastin as First- Line Maintenance Therapy Improved Progression-Free Survival in Advanced Lung Cancer

Study is Second Positive Phase III Trial of Tarceva as First-Line Maintenance Therapy
May 28, 2009

Astellas Announces New Vice President of Marketing
May 28, 2009

Astellas Receives FDA Approval For Use of Prograf® (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients
May 14, 2009

Data from the Phase III SATURN Study Show Tarceva Improved Progression-Free Survival When Used as a First-Line Maintenance Therapy for Advanced Non-Small Cell Lung Cancer

Data Showed Tarceva Improved PFS in Patients with Both Non-Squamous Cell Carcinoma and Squamous Cell Carcinoma
Apr 1, 2009

Astellas Appoints New US President and CEO

Company continues path toward goal to become global category leader
Mar 31, 2009

Astellas Launches Vaprisol® (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia

Arginine vasopressin (AVP) receptor antagonist now available in new premixed formulation
Mar 19, 2009

OSI Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Tarceva as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer

Roche Submits Marketing Authorization Application for Approval of Tarceva as a First-line Maintenance Therapy in Europe
Mar 16, 2009

Astellas to Terminate Offer for CV Therapeutics

Show per page

Statements

Careers

Stay Connected

Get only the email alerts you want.

Media Contacts

For media inquiries and reporter requests, please click here to fill out a request form.

Our communications team will respond to verified media requests within 24-48 hours as appropriate.

If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.

Download Fact Sheet

Sustainability

Investors

Explore U.S. Products

News Releases

You are now leaving XTANDI.com

You are now leaving newsroom.astellas.com.